Current Affairs

FDA OKs Perioperative Immunotherapy for Head and Neck Cancer

(MEDPAGE today)-Keytruda for patients with domestic advanced transactions locally accepted PD-L1, continued a local affected treatment with radiotherapy with or …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button